APSR2026-640

 
Late-Breaking
Submitted
Poster Presentation
 
AP02-016
P24
 
Format: PPTX Only
https://storage.unitedwebnetwork.com/files/1285/1206458-46904-APSR26_Poster Template_411644_431154.pdf
Format: PDF Only
05. Respiratory Infections (non-tuberculous)
14

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Kin Wang TO * Prince of Wales Hospital Medicine Hong Kong Hong Kong
Shu Ling TSO - Chinese University of Hong Kong Medicine Hong Kong Hong Kong
Ching Yee LEUNG - Chinese University of Hong Kong Medicine Hong Kong Hong Kong
Phoebe Wai Kwan TSE - Prince of Wales Hospital Medicine Hong Kong Hong Kong
Stephanie Wing Tone HO - Prince of Wales Hospital Medicine Hong Kong Hong Kong
Christopher CHAN - Prince of Wales Hospital Medicine Hong Kong Hong Kong
Charlotte Ho Ying LAU - Prince of Wales Hospital Medicine Hong Kong Hong Kong
Joyce Ka Ching NG - Prince of Wales Hospital Medicine Hong Kong Hong Kong
Rachel Lai Ping LO - Prince of Wales Hospital Medicine Hong Kong Hong Kong
Wing Ho YIP - Prince of Wales Hospital Medicine Hong Kong Hong Kong
Jenny Chun Li NGAI - Prince of Wales Hospital Medicine Hong Kong Hong Kong
Fanny Wai San KO - Prince of Wales Hospital Medicine Hong Kong Hong Kong
Ken Ka Pang CHAN - Chinese University of Hong Kong Medicine Hong Kong Hong Kong
David Shu Cheong HUI - Chinese University of Hong Kong Medicine Hong Kong Hong Kong
 
Presenting Author Details
Kin Wang
TO
tokw617@yahoo.com.hk
+85297180092
51-60
 
Original Research
The role of Streptococcus Pneumoniae urinary antigen test in community acquired pneumonia in a tertiary hospital
Maximum 25 words
Abstract Content
Community‑acquired pneumonia (CAP) is a common cause of hospitalization. This prospective cohort described the demographic characteristics of hospitalized patients with CAP admitted through the emergency department in a tertiary hospital in Hong Kong between 2021 to 2025.
Clinical diagnosis of CAP was made if patient was admitted with either acute onset of respiratory symptoms or CXR changes with raised white blood cell count/fever.
A total of 1,550 patients were recruited prospectively. The cohort was predominantly male (64%), with a mean age of 70 ± 15 years. Acute respiratory symptoms were present in 93% of patients, 39% had fever on admission (>37.5 °C). The 3 most common comorbidities were hypertension(51%), diabetes(26%) and hyperlipidaemia(27%). The mean hospital stay was 9 ± 8 days. Antibiotic therapy was administered for a mean of 10 ± 8 days. In- house urinary antigen testing for Streptococcus pneumoniae was performed in 781 (62.6%) patients, which was positive in 5.1% of tested cases. Blood cultures were performed in 1017(66%) patients, which was positive in 46(3%) of patients. 876(57%) sputum samples were culture positive with 49(18%) Haemophilus influenzae, 43 (16%) Pseudomonas aeruginosa, 28(10%) Klebsiella pneumoniae complex, and 18(6%) Streptococcus pneumoniae. Among the 40 patients with positive Streptococcus pneumoniae urine antigen, only 2 and 5 patients were also positive for blood and sputum culture respectively. Thirty five were sputum culture negative. Six patients were sputum positive but urine antigen negative.
Hospitalized CAP patients in Hong Kong were predominantly elderly with significant comorbidity. Microbiological confirmation was obtained from sputum cultures in over 50% of cases, while urinary antigen testing is useful to identify a high proportion of sputum culture negative Streptococcus pneumoniae CAP.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Community acquired pneumonia, urinary antigen test, epidemiology
maximum 3 keywords and no abbreviations, separated by commas
I would like to acknowledge Dr. Grace Lui, Dr. Rashid Lui, Dr. Ann Chan who have also contributed to case recruitment. This abstract is part of the results of a study which has received funding from Research Matching Grant Scheme of MERCK, SHARP & DOHME (ASIA) LTD
284